98 related articles for article (PubMed ID: 25030584)
1. [New strategies in the proteomic research on tumor stem cells].
Li M
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):321-3. PubMed ID: 25030584
[No Abstract] [Full Text] [Related]
2. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
Wang M; Xiao J; Jiang J; Qin R
Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110
[No Abstract] [Full Text] [Related]
3. [An update: stem cell and cancer stem cells].
Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):511-2. PubMed ID: 20021959
[No Abstract] [Full Text] [Related]
4. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
[TBL] [Abstract][Full Text] [Related]
5. Cancer: stem cells and brain tumours.
Dirks PB
Nature; 2006 Dec; 444(7120):687-8. PubMed ID: 17151644
[No Abstract] [Full Text] [Related]
6. Proteomic profiling of tumor-initiating cells in HT-29 human colorectal cancer cells.
Lee HN; Park SH; Lee EK; Bernardo R; Kim CW
Biochem Biophys Res Commun; 2012 Oct; 427(1):171-7. PubMed ID: 22995320
[TBL] [Abstract][Full Text] [Related]
7. [Updates on study of glioma stem cells].
Zhou ZH; Yi L; Bian XW
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):201-3. PubMed ID: 17535692
[No Abstract] [Full Text] [Related]
8. In search of liver cancer stem cells.
Ma S; Chan KW; Guan XY
Stem Cell Rev; 2008 Sep; 4(3):179-92. PubMed ID: 18663610
[TBL] [Abstract][Full Text] [Related]
9. Targeting brain-tumor stem cells.
Stupp R; Hegi ME
Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
[No Abstract] [Full Text] [Related]
10. The complexity of identifying cancer stem cell biomarkers.
Khan Z; Shervington A; Munje C; Shervington L
Cancer Invest; 2013 Jul; 31(6):404-11. PubMed ID: 23758188
[TBL] [Abstract][Full Text] [Related]
11. [Progress of research on breast cancer stem cell markers].
Liu X; Li W; Fu L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):282-4. PubMed ID: 24915825
[No Abstract] [Full Text] [Related]
12. Will identification of a prostate cancer stem cell lead to its cure?
Garraway IP
Urol Oncol; 2012; 30(4):351-2. PubMed ID: 22930822
[No Abstract] [Full Text] [Related]
13. CD133: molecule of the moment.
Mizrak D; Brittan M; Alison M
J Pathol; 2008 Jan; 214(1):3-9. PubMed ID: 18067118
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma cancer stem cells--from concept to clinical application.
Stopschinski BE; Beier CP; Beier D
Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells in the central nervous system--a critical review.
Prestegarden L; Enger PØ
Cancer Res; 2010 Nov; 70(21):8255-8. PubMed ID: 20959482
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells and tumor metastasis: first steps into uncharted territory.
Dalerba P; Clarke MF
Cell Stem Cell; 2007 Sep; 1(3):241-2. PubMed ID: 18371356
[TBL] [Abstract][Full Text] [Related]
17. CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature.
Kusumbe AP; Mali AM; Bapat SA
Stem Cells; 2009 Mar; 27(3):498-508. PubMed ID: 19253934
[TBL] [Abstract][Full Text] [Related]
18. Prominin1 (CD133) as an intestinal stem cell marker: promise and nuance.
Montgomery RK; Shivdasani RA
Gastroenterology; 2009 Jun; 136(7):2051-4. PubMed ID: 19409288
[No Abstract] [Full Text] [Related]
19. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
[TBL] [Abstract][Full Text] [Related]
20. Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?
Neuzil J; Stantic M; Zobalova R; Chladova J; Wang X; Prochazka L; Dong L; Andera L; Ralph SJ
Biochem Biophys Res Commun; 2007 Apr; 355(4):855-9. PubMed ID: 17307142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
